Literature DB >> 23242814

Clinical characteristics of Mikulicz's disease as an IgG4-related disease.

Masafumi Moriyama1, Akihiko Tanaka, Takashi Maehara, Yukiko Ohyama, Mayumi Shimizu, Hitoshi Nakashima, Jun-Nosuke Hayashida, Shoichi Shinozaki, Yoshiaki Kubo, Sachiko Furukawa, Toshihiro Kikuta, Seiji Nakamura.   

Abstract

OBJECTIVES: Mikulicz's disease (MD) was considered to be a subtype of Sjögren's syndrome (SS), based on histopathological similarities. However, recent studies have indicated that patients with MD show high serum IgG4 concentration, and suggested that MD is one of "IgG4-related disease" and distinguishable from SS. Therefore, we clinically and histopathologically examined the disease states of MD and SS in detail.
MATERIALS AND METHODS: Twenty patients with Mikulicz's disease and 18 with SS were comparatively studied to determine clinical characteristics in MD patients.
RESULTS: Sialography in MD patients did not show the "apple-tree sign" typically seen in SS. Serologically, high serum IgG4 levels but not anti-SS-A or anti-SS-B antibodies were observed in MD. SS showed lymphocytic infiltration of various subsets with atrophy or severe destruction of the acini, while MD showed selective infiltration of IgG4+ plasma cells with hyperplastic germinal centers and mild acini destruction. Corticosteroid treatment of MD reduced IgG and IgG4 levels and improved salivary function. A negative correlation between disease duration and increasing rate of salivary flow was observed in MD.
CONCLUSIONS: These results suggested that the pathogenesis of MD might be different from those of SS. CLINICAL RELEVANCE: early diagnosis and treatment of MD is important for the improvement of salivary function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242814     DOI: 10.1007/s00784-012-0905-z

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  22 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  A clinicopathologic study of Mikulicz's disease.

Authors:  W S MORGAN; B CASTLEMAN
Journal:  Am J Pathol       Date:  1953 May-Jun       Impact factor: 4.307

Review 3.  Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy).

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Susumu Sugai; Kohzoh Imai
Journal:  Autoimmun Rev       Date:  2004-11-17       Impact factor: 9.754

Review 4.  Mikulicz's disease and systemic IgG4-related plasmacytic syndrome (SIPS).

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Yasuyoshi Naishiro; Hiroyuki Isshiki; Mikiko Ohara; Chisako Suzuki; Hiroyuki Yamamoto; Yasuo Kokai; Tetsuo Himi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2008-02

5.  Sonographic diagnosis for Mikulicz disease.

Authors:  Mayumi Shimizu; Masafumi Moriyama; Kazutoshi Okamura; Toshiyuki Kawazu; Toru Chikui; Tazuko K Goto; Yukiko Ohyama; Seiji Nakamura; Kazunori Yoshiura
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-05-17

Review 6.  [IgG4-related disease-the diagnostic confusion and how to avoid it].

Authors:  Yasufumi Masaki; Hisanori Umehara
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2009-12

7.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 8.  The histopathology of Sjögren's syndrome in labial salivary gland biopsies.

Authors:  J S Greenspan; T E Daniels; N Talal; R A Sylvester
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1974-02

9.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

10.  Inflammatory lesions of the lung, submandibular gland, bile duct and prostate in a patient with IgG4-associated multifocal systemic fibrosclerosis.

Authors:  Ghullam Hamed; Kenji Tsushima; Masanori Yasuo; Keishi Kubo; Seiichi Yamazaki; Shigeyuki Kawa; Hideaki Hamano; Hiroshi Yamamoto
Journal:  Respirology       Date:  2007-05       Impact factor: 6.424

View more
  13 in total

1.  Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren's Syndrome.

Authors:  Antónia Szántó; Katalin Szabó; Gábor Nagy; Csaba Molnár; Margit Zeher
Journal:  Pathol Oncol Res       Date:  2016-01-19       Impact factor: 3.201

2.  Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.

Authors:  Takashi Maehara; Hamid Mattoo; Miho Ohta; Vinay S Mahajan; Masafumi Moriyama; Masaki Yamauchi; Jefte Drijvers; Seiji Nakamura; John H Stone; Shiv S Pillai
Journal:  Ann Rheum Dis       Date:  2016-06-29       Impact factor: 19.103

3.  Association of TCR-signaling pathway with the development of lacrimal gland benign lymphoepithelial lesions.

Authors:  Jian-Min Ma; Yi-Xin Cui; Xin Ge; Jing Li; Jin-Ru Li; Xiao-Na Wang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

4.  Disruption of tight junction structure contributes to secretory dysfunction in IgG4-related sialadenitis.

Authors:  Sai-Nan Min; Li-Ling Wu; Yan-Yan Zhang; Wen-Xuan Zhu; Xin Cong; Guang-Yan Yu
Journal:  J Mol Histol       Date:  2019-12-21       Impact factor: 2.611

5.  Clinical relevance of Küttner tumour and IgG4-related dacryoadenitis and sialoadenitis.

Authors:  S Furukawa; M Moriyama; S Kawano; A Tanaka; T Maehara; J-N Hayashida; Y Goto; T Kiyoshima; H Shiratsuchi; Y Ohyama; M Ohta; Y Imabayashi; S Nakamura
Journal:  Oral Dis       Date:  2014-06-25       Impact factor: 3.511

6.  Clinicopathological characteristics of immunoglobulin G4-related sialadenitis.

Authors:  Wei Li; Yan Chen; Zhi-Peng Sun; Zhi-Gang Cai; Tong-Tong Li; Lei Zhang; Min-Xian Huang; Hong Hua; Mei Li; Xia Hong; Jia-Zeng Su; Zhu-Yan Zhang; Yan-Ying Liu; Jing He; Zhan-Guo Li; Yan Gao; Guang-Yan Yu
Journal:  Arthritis Res Ther       Date:  2015-07-21       Impact factor: 5.156

7.  Organ Correlation in IgG4-Related Diseases.

Authors:  Satomi Koizumi; Terumi Kamisawa; Sawako Kuruma; Taku Tabata; Kazuro Chiba; Susumu Iwasaki; Go Kuwata; Takashi Fujiwara; Junko Fujiwara; Takeo Arakawa; Koichi Koizumi; Kumiko Momma
Journal:  J Korean Med Sci       Date:  2015-05-13       Impact factor: 2.153

Review 8.  Gallium SPECT/CT in evaluation of IgG4-related disease: A case report and literature review.

Authors:  Tzyy-Ling Chuang; Bao-Bao Hsu; Chen-Lin Chi; Yuh-Feng Wang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 9.  Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review.

Authors:  Ilaria Puxeddu; Riccardo Capecchi; Filippo Carta; Antonio Gaetano Tavoni; Paola Migliorini; Roberto Puxeddu
Journal:  J Immunol Res       Date:  2018-04-01       Impact factor: 4.818

10.  Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents.

Authors:  Xia Hong; Yan-Yan Zhang; Wei Li; Yan-Ying Liu; Zhen Wang; Yan Chen; Yan Gao; Zhi-Peng Sun; Xin Peng; Jia-Zeng Su; Zhi-Gang Cai; Lei Zhang; Jing He; Li-Min Ren; Hong-Yu Yang; Zhan-Guo Li; Guang-Yan Yu
Journal:  Arthritis Res Ther       Date:  2018-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.